Overview

A Study to Investigate the Effect of Oral Ticagrelor on the Pharmacokinetics of Oral Rosuvastatin When Given in Healthy Participants

Status:
COMPLETED
Trial end date:
2024-10-08
Target enrollment:
Participant gender:
Summary
The purpose of this study is to measure the effect of ticagrelor on the pharmacokinetics (PK) of rosuvastatin in healthy participants.
Phase:
PHASE1
Details
Lead Sponsor:
AstraZeneca
Collaborator:
Parexel
Treatments:
Rosuvastatin Calcium
Ticagrelor